Sterling Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$794K Buy
3,036
+1
+0% +$256 0.2% 50
2026
Q2
$764K Buy
3,035
+2
+0.1% +$430 0.19% 55
2026
Q1
$660K Buy
3,033
+2
+0.1% +$444 0.18% 52
2025
Q4
$693K Buy
3,031
+149
+5% +$33.9K 0.2% 50
2025
Q3
$667K Buy
2,882
+2
+0.1% +$407 0.2% 52
2025
Q2
$535K Buy
+2,880
New +$535K 0.18% 55
2024
Q4
$527K Buy
2,967
+1
+0% +$184 0.19% 57
2024
Q3
$586K Buy
2,966
+2
+0.1% +$373 0.22% 56
2024
Q2
$508K Buy
2,964
+114
+4% +$18.9K 0.24% 54
2024
Q1
$519K Buy
2,850
+2
+0.1% +$345 0.26% 51
2023
Q4
$441K Buy
+2,848
New +$415K 0.25% 56

Other funds holding ABBV

Sterling Wealth Management's ABBV Position: Q3 2026 in Review

Sterling Wealth Management increased its AbbVie (ABBV) stake by 0.03% in Q3 2026, buying an estimated $256 and bringing the position to 3,036 shares worth $794K. The position accounts for 0.2% of the portfolio, ranked #50.

Sterling Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Sterling Wealth Management held 3,036 shares of AbbVie worth $794K as of Q3 2026.
  • Sterling Wealth Management bought 1 AbbVie share in Q3 2026, an estimated $256.
  • AbbVie made up 0.2% of Sterling Wealth Management's portfolio in Q3 2026, its #50 holding.
  • Sterling Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sterling Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.